Sun Pharmaceutical Industries merger & restructuring announcements

Merger & RestructuringSun Pharmaceutical Industries Ltd SUNPHARMA

Sun Pharmaceutical Industries Merger & Restructuring Worth ₹9.5 Cr

Sun Pharma incorporates a new treasury subsidiary in GIFT City, Gandhinagar. Initial equity subscription is approximately ₹9.50 Crore for group treasury operations.

Value

₹9.50 Cr

Merger & RestructuringSun Pharmaceutical Industries Ltd SUNPHARMA

Sun Pharmaceutical Industries Merger & Restructuring

Sun Pharma announced that Organon stockholders approved the proposed merger, moving the acquisition forward. The deal remains subject to remaining customary closing conditions.

Merger & RestructuringSun Pharmaceutical Industries Ltd SUNPHARMA

Sun Pharmaceutical Industries Merger & Restructuring

Sun Pharmaceutical Industries Limited incorporated a new 100% subsidiary, Sun Pharma America, Inc., in the USA on April 23, 2026. The entity belongs to the pharmaceutical industry and was established for internal group structuring purposes through initial cash consideration.